chr2-30726801-G-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_144575.3(CAPN13):c.*31-3565C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.449 in 151,930 control chromosomes in the GnomAD database, including 15,497 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.45 ( 15497 hom., cov: 32)
Consequence
CAPN13
NM_144575.3 intron
NM_144575.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.0260
Publications
3 publications found
Genes affected
CAPN13 (HGNC:16663): (calpain 13) The calpains, calcium-activated neutral proteases, are nonlysosomal, intracellular cysteine proteases. The mammalian calpains include ubiquitous, stomach-specific, and muscle-specific proteins. The ubiquitous enzymes consist of heterodimers with distinct large, catalytic subunits associated with a common small, regulatory subunit. This gene encodes a member of the calpain large subunit family. [provided by RefSeq, Jun 2012]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.628 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CAPN13 | NM_144575.3 | c.*31-3565C>G | intron_variant | Intron 22 of 22 | ENST00000295055.12 | NP_653176.2 | ||
| CAPN13 | XR_939741.4 | n.2898C>G | non_coding_transcript_exon_variant | Exon 24 of 24 | ||||
| CAPN13 | XM_011533161.4 | c.*609C>G | 3_prime_UTR_variant | Exon 23 of 23 | XP_011531463.1 | |||
| CAPN13 | XM_047446332.1 | c.*31-1904C>G | intron_variant | Intron 22 of 22 | XP_047302288.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.449 AC: 68095AN: 151812Hom.: 15478 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
68095
AN:
151812
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.449 AC: 68152AN: 151930Hom.: 15497 Cov.: 32 AF XY: 0.449 AC XY: 33315AN XY: 74264 show subpopulations
GnomAD4 genome
AF:
AC:
68152
AN:
151930
Hom.:
Cov.:
32
AF XY:
AC XY:
33315
AN XY:
74264
show subpopulations
African (AFR)
AF:
AC:
20404
AN:
41442
American (AMR)
AF:
AC:
5807
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
AC:
1680
AN:
3470
East Asian (EAS)
AF:
AC:
3350
AN:
5182
South Asian (SAS)
AF:
AC:
2450
AN:
4820
European-Finnish (FIN)
AF:
AC:
4917
AN:
10510
Middle Eastern (MID)
AF:
AC:
121
AN:
294
European-Non Finnish (NFE)
AF:
AC:
28094
AN:
67932
Other (OTH)
AF:
AC:
941
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1946
3893
5839
7786
9732
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
636
1272
1908
2544
3180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2034
AN:
3468
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.